- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/207 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine-adenine dinucleotide or nicotinamide-adenine dinucleotide
Patent holdings for IPC class C07H 19/207
Total number of patents in this class: 281
10-year publication summary
|
26
|
27
|
24
|
28
|
34
|
26
|
25
|
20
|
24
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pacific Biosciences of California, Inc. | 759 |
16 |
| Atea Pharmaceuticals, Inc. | 74 |
15 |
| Janssen Biopharma, Inc. | 40 |
9 |
| Arcus Biosciences, Inc. | 136 |
8 |
| Bontac Bio-Engineering (Shenzhen) Co., Ltd | 72 |
8 |
| Nucana plc | 84 |
7 |
| Gilead Sciences, Inc. | 2032 |
6 |
| Idenix Pharmaceuticals LLC | 62 |
6 |
| Wave Life Sciences Ltd. | 166 |
6 |
| Janssen Pharmaceuticals, Inc. | 429 |
5 |
| The Johns Hopkins University | 5651 |
5 |
| Merck Sharp & Dohme LLC | 3753 |
5 |
| Life Technologies Corporation | 3279 |
4 |
| Kaneka Corporation | 4496 |
4 |
| Takeda Pharmaceutical Company Limited | 2707 |
4 |
| Alios BioPharma, Inc. | 66 |
4 |
| Invirsa, Inc. | 11 |
4 |
| Abbisko Therapeutics Co., Ltd. | 109 |
4 |
| Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. | 6 |
4 |
| Pyrotech (Beijing) Biotechnology Co., Ltd. | 6 |
4 |
| Other owners | 153 |